Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales there of its biosimilar ...
From one Swiss CDMO to another. That’s the course for Wolfgang Wienand, who plans to jump from his role as Siegfried’s CEO ...
The company that is backed by Amgen (AMGN.O) , opens new tab and Japan's SoftBank ... Treasury yields weigh 8:01 PM UTC · Updated ago Autos & Transportationcategory Tesla laying off more than 10% of ...
Even with discounts that reach as high as 86%, Humira biosimilars are finding it difficult to take market share away from the ...
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
(Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales ... its biosimilar Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita ...
(Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor U.S. sales ... its biosimilar Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita ...
Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor US sales ... Swiss drugmaker Sandoz launched its biosimilar Hyrimoz with the same prices as Boehringer and ...
In a Worker Adjustment and Retraining Notification Act (WARN) notice, BMS said it's laying off 252 staffers at 3545 ... a KRAS inhibitor that's going up against Amgen's Lumakras.
Due to slow uptake of its Humira biosimilar Cyltezo in the U.S., Boehringer Ingelheim is laying off an undisclosed number of ...